We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Light and Ultrasound Waves Reveal Extent of Skin Cancer

By HospiMedica International staff writers
Posted on 11 Dec 2017
A new study demonstrates that multispectral optoacoustic tomography (MSOT) allows three-dimensional (3D) imaging of deep non-melanoma skin tumors (NMSCs).

Developed by the Singapore Bioimaging Consortium (SBIC), Munich Technical University (TUM; Germany), the Skin Research Institute of Singapore (SRIS), and other institutions, MSOT is a volumetric imaging technique that can be used to differentiate between tissue chromophores and exogenous contrast agents based on differences in their spectral signatures, and which can provide high-resolution imaging of functional and molecular contrast at centimeter scale depth, providing more precise Mohs micrographic surgery (MMS).

The researchers used handheld MSOT probes for 3D imaging in 21 Asian patients with NMSC. More...
The results showed that both tumors and their oxygenation parameters could be distinguished from normal skin endogenously. Lesion dimensions were extracted from the MSOT spectral melanin component with 3D spatial resolution of up to 80 μm, with good correlation to histology of the excised tumors. Real-time 3D imaging also provided data on lesion morphology and the neovasculature, both indicators of the tumor’s aggressiveness. The study was published in the September 2017 issue of Photoacoustics.

“As skin cancer becomes increasingly prevalent, new skin imaging techniques providing non-invasive visualization without the need for excisional skin biopsy can help dermatologists plan the excision surgeries more effectively and accurately,” said lead author Professor Malini Olivo, PhD, head of the bio-optical imaging group at SBIC. “This positively impacts the long-term outcome of these procedures. This first-in-man study has successfully demonstrated that the use of MSOT can vastly improve the accuracy of the diagnosis and effectiveness of the treatment of non-melanoma skin cancer.”

“The ability to image skin cancer in 3D in-vivo will prove to be the disruptive technology for skin cancer management in the future,” concluded senior author Professor Steven Thng, executive director of SRIS. “This will change the paradigm of how skin cancer will be managed, as dermatosurgeons will now be able to visualize the tumor before surgery and individualize surgery based on tumor characteristics and size. This will minimize relapse rates due to inadequate surgery, and reduce unnecessary scarring because of oversampling.”

MMS is a surgical technique for the removal of certain cutaneous carcinomas that allows precise microscopic marginal control. It has become the treatment of choice for several NMSCs, such as basal cell and squamous cell carcinomas at high risk for local recurrence. Advantages of MMS include superior cure rates, maximal tissue conservation, low cost relative to that of radiation therapy, excision, or surgery, and negligible risk of complications from general anesthesia.

Related Links:
Singapore Bioimaging Consortium
Munich Technical University
Skin Research Institute of Singapore

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.